Global CDMO Tours & Expert Insights
Get a glimpse into our development, analytical and clinical and commercial manufacturing services across our seven sites.
Meet AGC Biologics, your friendly CDMO expert
Learn About Us
Our CEO, Alberto Santagostino, introduces AGC Biologics and shares what makes us stand out from other CDMOs.
Virtually tour our sites & facilities across the globe
Seattle Campus Tour
Explore AGC Biologics global headquarters site, providing mammalian and microbial services in Seattle, WA, USA.
Seattle Microbial Line
Take a virtual tour of our new microbial manufacturing line at our Seattle, WA, USA facilities.
Heidelberg Facility Tour
Virtually tour the expansion of AGC Biologics' Heidelberg site, which includes a warehouse, sampling & weighing center, additional lab spaces and expanded microbial, pDNA, and mRNA capabilities.
Milan Expansion
The expansion of the Milan facility allows for large-scale commercial viral vector work, suspension capabilities (PD, GMP), both allogeneic and autologous cell therapy, and small-scale fill/finish.
Check out our video series from our experts in Milan about the future of cell & gene therapy
Addressing Cell Therapy Trends
Listen to Alessandra Gatti, Cell Process Development Director at AGC Biologics talk about emerging trends within the cell therapy industry.
Delivering a GMP Process for ATMPs
Francesca Bellintani, MSAT Director, and overall expert on manufacturing cell and gene therapies shares how her team creates proven cGMP processes.
Building Better Analytical Methods for ATMPs
AGC Biologics' Analytical Method Development Director, Francesca Rossetti, talks about how we are evolving analytical testing capabilities for advanced therapies.
Navigating the Changing ATMP Market
Luca Alberici, Sr. VP and General Manager, of the AGC Biologics site in Milan discusses the changing cell and gene therapy market.
Creating New Standards for ATMP Manufacturing
Dive into how AGC Biologics is shaping the future of manufacturing for advanced therapies with Sabrina Cazzaniga, Sr. Director of GMP Manufacturing.
Building Standardized Viral Vector Platforms
Margherita Neri, Director of Vector Process Development, shares how AGC Biologics has built multiple successful viral vector platforms.
Addressing Regulatory & Quality in Cell and Gene
Listen to Giuliana Vallanti on how AGC Biologics has made quality a priority for all our processes, leading to successful regulatory approval for many advanced therapy products.
Process development speeding up cell & gene therapies
Win the Cell & Gene Therapy Race with Our Process Development
We offer industry-leading process development with more than 95% of our analytics performed in-house.